The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
Biomaterials Science 2020
DOI: 10.1016/b978-0-12-816137-1.00030-1
|View full text |Cite
|
Sign up to set email alerts
|

Microparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 241 publications
0
2
0
Order By: Relevance
“…Generally, microparticles face limitations due to their size being larger than nanoparticles. Microparticles can penetrate into cells less than NPs so they are used less in biological applications . Biotinylated streptavidin modified PLGA microparticles have shown promising therapeutic effects in the treatment of mammary tumors.…”
Section: Biodegradable Platforms In Vaccine Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…Generally, microparticles face limitations due to their size being larger than nanoparticles. Microparticles can penetrate into cells less than NPs so they are used less in biological applications . Biotinylated streptavidin modified PLGA microparticles have shown promising therapeutic effects in the treatment of mammary tumors.…”
Section: Biodegradable Platforms In Vaccine Deliverymentioning
confidence: 99%
“…Microparticles can penetrate into cells less than NPs so they are used less in biological applications. 134 Biotinylated streptavidin modified PLGA microparticles have shown promising therapeutic effects in the treatment of mammary tumors. Biotinylated SA complex increases the immunogenicity of PLGA microparticles.…”
Section: Biodegradable Platforms In Vaccine Deliverymentioning
confidence: 99%